Quarterly Journal of Nuclear Medicine and Molecular Imaging

Papers
(The TQCC of Quarterly Journal of Nuclear Medicine and Molecular Imaging is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-07-01 to 2025-07-01.)
ArticleCitations
Role of 18F-FDG-PET/CT in assessment of pediatric Hodgkin's lymphoma12
Osteomyelitis in complicated bones: the role of FDG PET/CT12
Reduction of emission time for [68Ga]Ga-PSMA PET/CT using the digital biograph vision: a phantom study11
Current radioisotopes and radiopharmaceuticals for radiosynoviorthesis: basic and applied characteristics, production and availability11
Nuclear cardiac imaging for the diagnosis and management of heart failure: what can be learned from recent guidelines?11
[68Ga]DOTA-TATE PET for the detection of early transplant rejection in a heterotopic allograft heart transplantation model of the rat: a pilot study10
The role of PET/CT in connective tissue disorders: systemic sclerosis, Sjögren's syndrome and systemic lupus erythematosus10
Hybrid positron emission tomography/magnetic resonance imaging in musculoskeletal conditions: be hybrid!10
The role of PET/CT in large vessel vasculitis and related disorders: diagnosis, extent evaluation and assessment of therapy response9
Pediatric nuclear medicine: continuing the evolution9
[18F]F-Choline PET/CT and 4D-CT in the evaluation of primary hyperparathyroidism: rivals or allies?8
Second radioiodine treatment hardly benefits TT-DTC patients with radioiodine-negative metastases on initial post-therapeutic whole-body scans8
FDG PET/CT in vascular graft infection: a pictorial review7
Radiation protection aspects for alpha therapies7
Volumetric PET parameters are predictive for the prognosis of locally advanced cervical cancer7
Theragnostics before we found its name7
Nuclear medicine and pediatric nephro-urology: a long-lasting successful partnership6
Challenges in theragnostics6
Adverse effects under immune checkpoint inhibitors on [18F]FDG PET/CT imaging6
Evaluation of quantitative imaging parameters in head and neck squamous cell carcinoma6
The role of [18F]FDG PET/CT in paraneoplastic autoimmune disorders: an umbrella review5
Technical concepts on blood pool phase SPECT (acquisition, reconstruction)5
Perceptual omission errors in positron emission tomography and computed tomography reporting4
Volumetric 68Ga-DOTA-TATE PET/CT for assessment of whole-body tumor burden as a quantitative imaging biomarker in patients with metastatic gastroenteropancreatic neuroendocrine tumors4
Imaging of dopamine transporter with [18F]LBT-999: initial evaluation in healthy volunteers4
Beta radioguided surgery: towards routine implementation?4
11C-methionine PET/MRI in postoperative patients after craniotomy: zero echo time and head atlas versus CT-based attenuation correction4
Side effects of theragnostic agents currently employed in clinical practice4
Theragnostics applications and challenges3
Image-guided surgery: from classical techniques to novel aspects and approaches3
Innovations in imaging modalities: a comparative review of MRI, long-axial field-of-view PET, and full-ring CZT-SPECT in detecting bone metastases3
F18-FET PET in pediatric brain tumors: integrative analysis of image derived parameters and clinico-pathological data3
Benefit of including CT urography in [68Ga]PSMA-11 PET/CT with low-dose CT: first results from a larger prostate cancer cohort analysis3
Local treatment of synovitis3
Fever of unknown origin in pediatrics: role of nuclear medicine3
Towards refining the utility of dual (18F-FDG / 18F-Choline) PET/CT for the management of hepatocellular carcinoma: a tertiary center study3
Evaluation and clinical quantification of neoplastic lesions and physiological structures in TOF- versus non-TOF-PET/MRI: a pilot study3
0.036109924316406